A mechanism for esophageal tumor-derived immunosuppression

Safety of Bifidobacterium breve, Bif195, employing a human exercise-induced intestinal permeability model: a randomised, double-blinded, placebo-controlled, parallel group trial.

Beneficial microbes·2022

Modulation, microbiota and inflammation in the adult CF gut: A prospective study.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2022

Metagenomic assembled plasmids of the human microbiome vary across disease cohorts.

Scientific reports·2022

Mapping the colorectal tumor microbiota.

Gut microbes·2021

The gut virome in Irritable Bowel Syndrome differs from that of controls.

Gut microbes·2021

The fecal mycobiome in patients with Irritable Bowel Syndrome.

Scientific reports·2021

Global Prevalence of Celiac Disease and Clinical Characteristics in the General Population: A Systematic Review and Meta-analysis.

Gastroenterology·2026

WNT-driven immune evasion promotes malignant transformation of BRAF-mutant colorectal cancer.

Gastroenterology·2026

WISP1 Drives Intestinal Fibrosis in Crohn's Disease via Metabolic and Rho/ROCK/MRTF-mediated cytoskeletal Remodeling.

Gastroenterology·2026

Fiber supplementation in irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.

Gastroenterology·2026

Liver regeneration CRISPR screen identifies E3 ligase NEURL1B regulates hepatocyte mitosis by destabilizing microtubule organizing centers.

Gastroenterology·2026

Prognostic Performance of Liver Stiffness Measurements in Primary Sclerosing Cholangitis: The Prospective FICUS cohort.

Gastroenterology·2026

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Frontiers in oncology·2026

Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.

Nature reviews. Cancer·2026

Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.

Clinical rheumatology·2026

Erratum to 'Clinical and Immunologic Features of Primary Enteric-Type Thymic Adenocarcinomas: A Rare Variant of a Rare Cancer' [JTO Clinical and Research Reports 7 (2026) 101019].

JTO clinical and research reports·2026

Mathematical and Mouse Models Identify Regulatory T Cell Influx as A Key Determinant of Acquired Resistance to PD-1 Immunotherapy.

Cancer research·2026

Peripheral cytokine distinguish recent from Mycobacterium tuberculosis infection and active tuberculosis.

Frontiers in microbiology·2026

Related Experiment Videos

A mechanism for esophageal tumor-derived immunosuppression

Related Concept Videos

Safety of Bifidobacterium breve, Bif195, employing a human exercise-induced intestinal permeability model: a randomised, double-blinded, placebo-controlled, parallel group trial.

Modulation, microbiota and inflammation in the adult CF gut: A prospective study.

Metagenomic assembled plasmids of the human microbiome vary across disease cohorts.

Mapping the colorectal tumor microbiota.

The gut virome in Irritable Bowel Syndrome differs from that of controls.

The fecal mycobiome in patients with Irritable Bowel Syndrome.

Global Prevalence of Celiac Disease and Clinical Characteristics in the General Population: A Systematic Review and Meta-analysis.

WNT-driven immune evasion promotes malignant transformation of BRAF-mutant colorectal cancer.

WISP1 Drives Intestinal Fibrosis in Crohn's Disease via Metabolic and Rho/ROCK/MRTF-mediated cytoskeletal Remodeling.

Fiber supplementation in irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.

Liver regeneration CRISPR screen identifies E3 ligase NEURL1B regulates hepatocyte mitosis by destabilizing microtubule organizing centers.

Prognostic Performance of Liver Stiffness Measurements in Primary Sclerosing Cholangitis: The Prospective FICUS cohort.

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.

Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.

Erratum to 'Clinical and Immunologic Features of Primary Enteric-Type Thymic Adenocarcinomas: A Rare Variant of a Rare Cancer' [JTO Clinical and Research Reports 7 (2026) 101019].

Mathematical and Mouse Models Identify Regulatory T Cell Influx as A Key Determinant of Acquired Resistance to PD-1 Immunotherapy.

Peripheral cytokine distinguish recent from Mycobacterium tuberculosis infection and active tuberculosis.

Related Experiment Videos

A mechanism for esophageal tumor-derived immunosuppression

Related Concept Videos

Related Articles